Clinical trial
Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for…
NCT00209521 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00209521 |
|---|---|
| Title | Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery |
| Official title | Phase 2, Randomized Study of AQUAVAN® Injection In Elective Coronary Artery Surgery With Comparison to DISOPRIVAN® Injectable Emulsion |
| Lead sponsor | Eisai Inc., Industry |
| Collaborators | PPD Development, LP Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ischemic Coronary Artery Disease, Coronary Artery Bypass Surgery |
| Intervention type | Drug |
| Interventions | fospropofol, propofol |
| Enrollment | 16 |
| Start date | Jun 1, 2002 |
| Primary completion | Jul 1, 2003 |
| Completion | Jul 1, 2003 |
| First posted | Sep 21, 2005 |
| Last update posted | Jun 11, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: